Jean Jacques Bienaime, Director at BioMarin Pharmaceutical, holds 8.45K shares in Keros Therapeutics (Ticker: KROS), holds 38.41K shares in Immunome (Ticker: IMNM), holds 20.84K shares in Incyte (Ticker: INCY).
What is the percentage of profitable transactions made by Jean Jacques Bienaime?
The percentage of profitable transactions made by Jean Jacques Bienaime is 46%.
What is the average return per transaction made by Jean Jacques Bienaime?
The average return per transaction made by Jean Jacques Bienaime is 12.20%.
What stocks does Jean Jacques Bienaime hold?
Jean Jacques Bienaime holds: BMRN, IMNM, KROS, IMUX, INCY, PTLA, NGSX, ITMN stocks.
What was Jean Jacques Bienaime’s latest transaction?
Jean Jacques Bienaime latest transaction was an Uninformative Buy of $11.70K.
What was Jean Jacques Bienaime's most profitable transaction?
Jean Jacques Bienaime’s most profitable transaction was an Informative Buy of IMNM stock on March 25, 2025. The return on the trade was 192.00%.
What is Jean Jacques Bienaime's role in BioMarin Pharmaceutical?
Jean Jacques Bienaime's role in BioMarin Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.